| GC15711-1mg |
|
879127-16-9 |
Aurora Kinase Inhibitor III
|
0 |
C21H18F3N5O |
|
|
|
| GC15711-500ug |
|
879127-16-9 |
Aurora Kinase Inhibitor III
|
0 |
C21H18F3N5O |
|
|
|
| GC15710-25mg |
|
89159-60-4 |
|
0 |
C16H14N2O3 |
|
|
|
| GC15710-10mg |
|
89159-60-4 |
|
0 |
C16H14N2O3 |
|
|
|
| GC15710-5mg |
|
89159-60-4 |
|
0 |
C16H14N2O3 |
|
|
|
| GC15710-1mg |
|
89159-60-4 |
|
0 |
C16H14N2O3 |
|
|
|
| GC15709-100mg |
|
914295-16-2 |
R788 disodium hexahydrate
|
0 |
C23H24FN6Na2O9P |
|
|
|
| GC15709-50mg |
|
914295-16-2 |
R788 disodium hexahydrate
|
0 |
C23H24FN6Na2O9P |
|
|
|
| GC15709-10mg |
|
914295-16-2 |
R788 disodium hexahydrate
|
0 |
C23H24FN6Na2O9P |
|
|
|
| GC15709-5mg |
|
914295-16-2 |
R788 disodium hexahydrate
|
0 |
C23H24FN6Na2O9P |
|
|
|
| GC15708-100mg |
|
— |
Cysteine Protease inhibitor hydrochloride
|
0 |
C18H15ClN4O |
|
|
|
| GC15708-50mg |
|
— |
Cysteine Protease inhibitor hydrochloride
|
0 |
C18H15ClN4O |
|
|
|
| GC15708-10mg |
|
— |
Cysteine Protease inhibitor hydrochloride
|
0 |
C18H15ClN4O |
|
|
|
| GC15708-2mg |
|
— |
Cysteine Protease inhibitor hydrochloride
|
0 |
C18H15ClN4O |
|
|
|
| GC15708-5mg |
|
— |
Cysteine Protease inhibitor hydrochloride
|
0 |
C18H15ClN4O |
|
|
|
| GC15706-10mM (in 1mL DMSO) |
|
50-78-2 |
Aspirin (Acetylsalicylic acid)
|
0 |
C9H8O4 |
|
|
|
| GC15706-50mg |
|
50-78-2 |
Aspirin (Acetylsalicylic acid)
|
0 |
C9H8O4 |
|
|
|
| GC15704-50mg |
|
1257323-83-3 |
|
0 |
C17H18N2O7 |
|
|
|
| GC15704-10mg |
|
1257323-83-3 |
|
0 |
C17H18N2O7 |
|
|
|
| GC15703-25mg |
|
96750-66-2 |
|
0 |
C14H20Cl4I2N2 |
|
|
|
